Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Equity Ratio (2016 - 2025)

Assembly Biosciences (ASMB) has 11 years of Equity Ratio data on record, last reported at 0.76 in Q3 2025.

  • For Q3 2025, Equity Ratio rose 193.52% year-over-year to 0.76; the TTM value through Sep 2025 reached 0.76, up 193.52%, while the annual FY2024 figure was 0.28, 6.8% down from the prior year.
  • Equity Ratio reached 0.76 in Q3 2025 per ASMB's latest filing, up from 0.22 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.9 in Q3 2021 and bottomed at 0.22 in Q2 2025.
  • Average Equity Ratio over 5 years is 0.64, with a median of 0.81 recorded in 2022.
  • Peak YoY movement for Equity Ratio: tumbled 67.9% in 2024, then surged 193.52% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.88 in 2021, then fell by 8.15% to 0.81 in 2022, then crashed by 63.01% to 0.3 in 2023, then dropped by 6.8% to 0.28 in 2024, then soared by 171.94% to 0.76 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.76 in Q3 2025, 0.22 in Q2 2025, and 0.27 in Q1 2025.